TY - JOUR
T1 - Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder
AU - Mühleisen, Thomas W.
AU - Mattheisen, Manuel
AU - Strohmaier, Jana
AU - Degenhardt, Franziska
AU - Priebe, Lutz
AU - Schultz, C. Christoph
AU - Breuer, René
AU - Meier, Sandra
AU - Hoffmann, Per
AU - Rivandeneira, Fernando
AU - Hofman, Albert
AU - Uitterlinden, André G.
AU - Moebus, Susanne
AU - Gieger, Christian
AU - Emeny, Rebecca
AU - Ladwig, Karl-Heinz
AU - Wichmann, H.-Erich
AU - Schwarz, Markus
AU - Kammerer-Ciernioch, Jutta
AU - Schlösser, Ralf G. M.
AU - Nenadic, Igor
AU - Sauer, Heinrich
AU - Mössner, Rainald
AU - Maier, Wolfgang
AU - Rujescu, Dan
AU - Lange, Christoph
AU - Ophoff, Roel A.
AU - Schulze, Thomas G.
AU - Rietschel, Marcella
AU - Nöthen, Markus M.
AU - Cichon, Sven
AU - AUTHOR GROUP
AU - Kahn, René S.
AU - Linszen, Don H.
AU - van Os, Jim
AU - Wiersma, Durk
AU - Bruggeman, Richard
AU - Cahn, Wiepke
AU - de Haan, Lieuwe
AU - Krabbendam, Lydia
AU - Myin-Germeys, Inez
AU - Wichmann, H. -Erich
AU - Breuer, Rene
AU - Nöthen, Markus
PY - 2012
Y1 - 2012
N2 - A recent study found genome-wide significant association between common variation in the gene neurocan (NCAN, rs1064395) and bipolar disorder (BD). In view of accumulating evidence that BD and schizophrenia partly share genetic risk factors, we tested this single-nucleotide polymorphism for association with schizophrenia in three independent patient-control samples of European ancestry, totaling 5061 patients and 9655 controls. The rs1064395 A-allele, which confers risk for BD, was significantly over-represented in schizophrenia patients compared to controls (p=2.28×10(-3); odds ratio=1.11). Follow-up in non-overlapping samples from the Schizophrenia Psychiatric GWAS Consortium (5537 patients, 8043 controls) provided further support for our finding (p=0.0239, odds ratio=1.07). Our data suggest that genetic variation in NCAN is a common risk factor for BD and schizophrenia
AB - A recent study found genome-wide significant association between common variation in the gene neurocan (NCAN, rs1064395) and bipolar disorder (BD). In view of accumulating evidence that BD and schizophrenia partly share genetic risk factors, we tested this single-nucleotide polymorphism for association with schizophrenia in three independent patient-control samples of European ancestry, totaling 5061 patients and 9655 controls. The rs1064395 A-allele, which confers risk for BD, was significantly over-represented in schizophrenia patients compared to controls (p=2.28×10(-3); odds ratio=1.11). Follow-up in non-overlapping samples from the Schizophrenia Psychiatric GWAS Consortium (5537 patients, 8043 controls) provided further support for our finding (p=0.0239, odds ratio=1.07). Our data suggest that genetic variation in NCAN is a common risk factor for BD and schizophrenia
U2 - 10.1016/j.schres.2012.03.007
DO - 10.1016/j.schres.2012.03.007
M3 - Article
C2 - 22497794
SN - 0920-9964
VL - 138
SP - 69
EP - 73
JO - Schizophrenia research
JF - Schizophrenia research
IS - 1
ER -